Stig joined Biomega in October 2020 after more than a decade at the specialty feed company, Hamlet Protein, where he was Vice President of Operations. Prior to his role at Hamlet Group, Stig held multiple positions across operations, sales, product and application management at several companies, including Palsgaard, Tetra Pak Filtration and Danisco (DuPont).
He brings more than 25 years’ experience in the human nutrition and animal feed industry to his role as CEO.
Chief Financial Officer
Espen joined Biomega in November 2020 and brings with him a wealth of experience and broad knowledge from previous roles in financial and performance management at rapid-growth manufacturing companies. Prior to joining the company, Espen held various CFO and management positions at Norwegian-based companies including Totaltek, Protan Group, Eitzen Maritime Services and Dynea. Most recently, Espen has worked as a management contractor for technical roadwork installation company Veidrift and leading protective clothing manufacturer Wenaas Workwear.
With a degree in Siviløkonom from Norges Handelshøyskole, Espen is a highly competent and driven individual with a passion for biotechnology.
Chief Technology Officer
Andrew joined the Biomega team in October 2019. He moved to Scandinavia in 1998 from Cape Town, South Africa, and has held Project, R&D and Technology management positions in Sweden and Norway. This background is within a range of industries, including: mining, pulp & paper, biorefining, oil & gas and industrial water treatment. Common for most of these positions has been the focus on process and technology development and environmental technologies.
After working within large-scale, high-efficiency production environments (at LKAB and Stora Enso, in Sweden), Andrew has been drawn to the flexibility, energy and innovation in smaller companies and start-ups (Vetco Gas Technology, Weyland Bioethanol, Sorbwater Technology), particularly those with a focus on resource recovery and sustainability. Andrew has a PhD in Chemical Engineering from the University of Cape Town.
Chief Commercial Officer
Dr Silke Middendorf joined Biomega in February 2022 and brings significant multinational and intercultural experience to the business. Holding a PhD in Biophysical chemistry, she has a proven track record in driving commercial strategy at global operations such as Pfizer and Symrise. Dr Middendorf will be responsible for leading the marketing and sales strategies, guiding growth projects to completion.
Chief Scientific Officer
Bjørn joined Biomega in August 2018. He has a background within biochemistry and nutrition, and prior to joining Biomega, he was a senior scientist at the National Institute of Nutrition and Seafood Research (NIFES). He has broad experience within both pre-clinical and clinical nutritional studies, mainly on the topic of dietary effects of proteins on health.
Liaset holds a PhD in nutrition from the University of Bergen.
Director of Sourcing
Harald has been part of the Norwegian aquaculture industry since 1992. His first engagement was in Hordafòr AS, a Norwegian Silage company, where he was QA-manager, Head of Sales and more. In 2000, he was one of the founders and shareholders of Biomega. Over the years he has been Head of Sales and a member of the board, and is currently Director of Sourcing.
Harald holds a master’s degree in fish health from the University of Bergen.
Director of Global Quality
Ingrid joined Biomega in September 2019 bringing with her vast experience in quality, innovation and development at several food producing companies in Norway, as well as the establishment of food factories in other countries.
She holds a masters in Food Science from the Norwegian University of Life Sciences (NMBU) and a masters in human nutrition from the University of Bergen, Faculty of Medicine and Dentistry, with her thesis completed at the Institute of Nutrition and Seafood Research (NIFES).